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Tuberculosis has been a scourge of humans over many millennia, but questions remain regarding its
evolution and epidemiology. Fossil biomarkers, such as DNA and long-chain mycolic acids, can be
detected in ancient skeletal and other materials. The phthiocerol dimycocerosate waxes are also robust
biomarkers for tuberculosis and sensitive methods are available for the detection of their mycocerosic
acid components. The presence of mycocerosic acids was investigated in 49 individuals from the
1837–1936 Coimbra Identified Skeletal Collection (Portugal), half with documentary data indicating
tuberculosis as a cause of death. Samples were hydrolysed, acidic components converted to penta-
fluorobenzyl esters, the non-hydroxylated long-chain esters isolated, and this fraction separated into
multimethyl-branched and other esters by normal phase high performance liquid chromatography.
Negative ion chemical ionisation gas chromatography mass spectrometry was used to detect diagnostic
C29, C30 and C32 mycocerosic acids. Mycocerosic acids were detected in archaeological material for the
first time, illustrating that they are valuable biomarkers for the diagnosis of ancient tuberculosis. A 72%
correlation with the Coimbra burial record supported TB as the major cause of death. In addition, 30% of
the skeletons, positive for mycocerosates, showed the presence of related long-chain mycolipenic acids.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
1.1. Ancient tuberculosis
It was estimated that there were 8–9 million new cases of
tuberculosis (TB) and 1.6 million deaths in 2005.1 The continuing
prevalence of this disease, caused byMycobacterium tuberculosis, is
partly due to the evolution of strains highly resistant to drug
treatment and a higher incidence of human immunodeficiency
virus (HIV) co-infection.1 Cyclical changes in TB epidemiology could
underlie these recent developments,2,3 so it is important to study
TB prevalence in ancient populations. By elucidating the origins and
history of TB, an increase in the understanding of epidemiological
patterns may develop.
Historically, the study of gross morphological change in archae-
ologically derived skeletal material, particularly spinal destruction
has been used for TB diagnosis in ancient populations.4 A concern isx: þ44(0)1214145925.
nnikin).
All rights reserved.the non-specificity of some of these gross morphological changes,
for example in rib lesions5,6 and general bone changes.6 Although TB
is principally a disease of the respiratory tract, it can result in bone
change in a lowpercentage of individuals.7–9 Unfortunately, there is
uncertainty surrounding the attribution of many bone changes to
TB10; other conditions, suchasbrucellosis andneoplasms,maycause
similar alterations.6 However, a dual biomarker study11 has shown
some support for macroscopic diagnostic methods, as have many
aDNA studies of TB.12–15
In the last decade, ancient DNA (aDNA) analyses, using spoli-
gotyping and sequencing techniques, have become established for
characterisation of a wide range of biological samples, as exem-
plified by recent reports.12–15 For ancient TB diagnosis, primers that
target the insertion sequence IS6110 are commonly used for iden-
tification.16–20 Ancient DNA analysis also has the potential to
discriminate between different species of the Mycobacterium
tuberculosis complex, such as human and bovine.21,22 However, care
must be taken when using the non-specific region of IS6110, as
weak cross-reactivity has been found with Mycobacterium fortu-
itum.23 Post-mortem oxidative and hydrolytic cleavage has also
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microbial DNA studies, recommendations for good laboratory
practice have been suggested.25,26 Finally, due to the sensitivity of
amplification, inferring whether a positive result is due merely to
infection or the onset of clinical TB could be difficult to determine.27
The use of chemically stable lipid biomarkers for TB diagnosis
has been investigated as an alternative approach to ancient disease
diagnosis. Mycobacteria produce a range of very unusual long-
chain lipids as components of the cell envelope, specific to the
genus.28 One such class, the mycolic acids, C70–C90, 2-alkyl,
3-hydroxy fatty acids, have been successfully detected in archaeo-
logical individuals,11,29,30 using reversed and normal phase high
performance liquid chromatography (HPLC) and fluorescence
detection of mycolic acids tagged with 9-chloromethylanthracene.
1.2. The biomarker
In this study, anotherclass ofmycobacterial lipids, themycocerosic
acids, was investigated as biomarkers for TB diagnosis in archaeo-
logical individuals. Mycocerosic acids (Figure 1) are long-chain mul-
timethyl-branched-chain fatty acids28 which are present in
representatives of M. tuberculosis, Mycobacterium bovis, Mycobacte-
rium gastri, Mycobacterium haemophilum, Mycobacterium kansasii,
Mycobacterium leprae, Mycobacterium marinum and Mycobacterium
ulcerans.31–35 The mycocerosic acids of the mycobacteria are found
mainly as phthiocerol dimycocerosate (PDIM) waxes or in phenolic
glycolipids.31–35 Their composition can be determined by simple gas
chromatography (GC), but certain types of acids have essentially the
same retention times.36–38 For example, a C29 mycocerosate with
three methyl branches may overlap with a C30 acid with four methyl
branches.31,37,38 In addition,M. tuberculosis produces a range of other
multimethyl branched fattyacids28,33 andC27mycolipenate (Figure1)
is one particularly characteristic acid that could easily be investigated
along with the mycocerosates.
In pioneering studies,39 Larsson and colleagues showed that C32
mycocerosates could be detected by GC–MS in five-day cultures of
tuberculosis patient sputum samples. Individual mycocerosates
have been determined successfully in clinical samples by selected
ion monitoring (SIM) negative ion chemical ionisation gas
chromatography mass spectrometry (NI–CI GC–MS).36,40 Using SIM
GC–MS improves the analytical sensitivity and simplifies biomarker
detection, as only the target analytes are monitored. Chemical
analysis of archaeological material for these lipids using SIM
GC–MS would thus provides a robust alternative technique to
corroborate diagnoses achieved by other means, such as osteolog-
ical changes, ancient DNA or mycolic acid biomarkers.
It is important to be able to recognise the characteristicM. tuber-
culosis pattern of mycocerosates, typically trimethyl C29 and tetra-
methyl C30 and C32.
31,32,37,38,40 In a limited systematic study,31 it was
shown that themycocerosates ofM. bovis hadmainly C26, C27, C29, C30
components, lacking the major amounts of the C32 mycocerosateCH3 CH3 CH3
CH3(CH2)m
COOH
n
CH3
COOHCH3(CH2)17
Mycocerosate Mycolipenate
For mycocerosate components:  m = 16-20, n = 2-4
C26 (m/z 395) m = 18, n = 2;  C27 (m/z 409) m = 16, n = 3; C29 (m/z 437) m = 
18, n = 3; C30 (m/z 451) m = 16, n = 4; C32 (m/z 479) m = 18, n = 4; C33 (m/z
493) m = 16, n = 5; C34 (m/z 507) m = 20, n = 4. 
C27 mycolipenate has m/z 407
Figure 1. Structures of C26–C34 mycocerosic and C27 mycolipenic acids from
M. tuberculosis. Mass spectral m/z values refer to negative ions observed on
fragmentation of pentafluorobenzyl esters.typical ofM. tuberculosis. It was later indicated38 that the attenuated
BCG vaccine strain ofM. bovis had essentially the samemycocerosate
profile as that ofM. tuberculosis. Extensive studies will be needed to
determine if mycocerosic acid profiles can distinguish between
infectionsdue toM.bovis andM. tuberculosisbut, in the present study,
attention will be concentrated on the major C29, C30 and C32 compo-
nents, characteristic for the human disease. The profile for mycocer-
osates fromM. leprae isdistinct inhavingaprofilewithadominantC34
component.34,38 There is a possibility that archaeologically derived
bone samples could be contaminated with the environmental
mycobacteria,M. kansasii andM. marinum. The mycocerosate profile
of the former resembles that of M. tuberculosis, but with a minor
proportion of the C32 component; that of the latter has mainly C27
with small proportions of C29 and C30.
31,32,38
1.3. The archaeological samples
Rib samples from individuals of the 19th and 20th century
Coimbra Identified Skeletal Collection were taken and analysed.
This Collection, curated by the Anthropological Museum of the
University of Coimbra, derives from the Cemetery of Conchada,
Coimbra, Portugal. This is a small in-use cemetery that serves
Coimbra University Hospital (CUH) and a variety of other sites in
and around Coimbra. The collection is ‘‘identified’’ because the
associated medical records are present for all individuals.
The collection comprises 505 individuals who died at CUH and
240 who died elsewhere; only those from CUH have been included
in this study. Within the CUH component of the skeletal collection,
there are 266 males and 239 females. Both adults and non-adults
are represented, but most were over 21 years at death. Born
between 1822 and 1921, the individuals died between 1904 and
1936, with ages at death ranging between 7 and 96 years.41 The
individuals were exhumed between 1916 and 1946 and are curated
at the University of Coimbra, Department of Anthropology, along
with their medical records. Tuberculosis, at 25% of the total, is the
commonest recorded cause of death in the Collection, followed by
cardiac disease (14%) and other respiratory diseases (13%). The
figure for TB mortality is high, but this correlates well with data
from UK hospital populations from around the same period.42
2. Materials and methods
2.1. Material analysed
The representative 49 individuals, chosen from the 505 skele-
tons in the Coimbra Collection,41,42 were all adults (>15 years old at
death), who died between 1910 and 1936, with 48% being associ-
ated with tuberculosis as a cause of death. The rib samples were
crushed to a fine powder using a mortar and pestle, cleaned thor-
oughly between samples with dichloromethane (DCM). Disposable
nitrile gloves were worn when handling sample material. Standard
heat killed lyophilised cells of the standard tuberculin strain,
M. tuberculosis PN,43 were provided by the Central VeterinaryTable 1
Elution scheme for fractionation of long-chain extracts on silica gel cartridges.
Fraction Heptane Toluene Dichloro-methane Vol/ml
1 100 0 0 6
2 97 3 0 6
3 90 10 0 6
4 80 20 0 6
5 50 50 0 6
6 0 100 0 6
7 0 100 0 6
8 0 0 100 6
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Figure 3. Optimisation of conditions for normal phase HPLC purification of multi-
methyl branched PFB esters, using chemical co-markers. (1) log k0 plot for decaf-
luorobenzophenone (DFBP), mycocerosic acid PFB ester (MY) and dodecanoic acid
bis-pentafuorophenyl-methyl ester (DPFM) as a function of ethyl acetate concentra-
tion (%) in heptane. (2) The corresponding separation in 98:2 heptane:ethyl acetate,
1 mlmin1. Column, Genesis silica 4 mm particle size, 250 mm by 4.6 mm at 30 C. (3)
Structures of the co-markers DPFM and DFBP.
MA
MY
FA
P P
MY 1 3 4 5 6 7 8MA P 2
Figure 2. TLC analysis of the 8 fractions fromnormal phase cartridge separation of long-
chain compounds fromM. tuberculosis PN, using the elution scheme detailed in Table 1.
MY,mycocerosic acid PFB ester;MA,mycolic acid PFB ester; P, phthiocerol; FA, other fatty
acid PFB ester. TLC developed in petrol 60–80 C:ethyl acetate, 9:1 and components
revealed by spraying with 10% ethanolic molybdophosphoric acid and charring.
Table 2
Retention factors of the decafluorobenzhydrol esters, mycocerosic acid PFB esters
and decafluorobenzophenone.
Compound k0
Hexanoic acid bis-pentafluorophenyl-methyl ester 0.26
Octanoic acid bis-pentafluorophenyl-methyl ester 0.18
Dodecanoic acid bis-pentafluorophenyl-methyl ester (DPFM) 0.12
Hexadecanoic acid bis-pentafluorophenyl-methyl ester 0.07
Octadecanoic acid bis-pentafluorophenyl-methyl ester 0.04
Mycocerosic acid PFB ester (MY) 0.22
Decafluorobenzophenone (DFBP) 0.29
Chromatographic conditions: a Gilson 305 HPLC pump coupled to an Applied
Biosystems 759AUV detector (263 nm)was used, with a Genesis silica 4 mm column,
250 mm by 4.6 mm i.d., developed with an isocratic solvent system of 98:2
heptane:ethyl acetate (1 mlmin1) at 30 C.
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12478 and M. bovis MNC 8 were cultivated as described previ-
ously.31 Analytical grade chemicals (Sigma–Aldrich, Poole, Dorset,
UK) and solvents (VWR International Ltd, Lutterworth, Leicester-
shire, UK) were used, unless stated otherwise.
2.2. Hydrolysis of biomass
Samples of bone (w1.0 g) and standard cells (50 mg) were
hydrolysed overnight at 100 C in sealed 8.5 ml Pyrex tubes, with
a PTFE-lined cap, using a solution of 30% w/v methanolic potassium
hydroxide (2 ml) and toluene (1 ml).36–38 After cooling to room
temperature, the tubes were cooled to 0 C in an ice bath. The
reaction mixtures were acidified to pH 1 by the addition of 10%
aqueous HCl (1 ml) and dropwise addition of concentrated HCl.
Long-chain compounds were extracted with diethyl ether
(31 ml). The combined organic extracts were evaporated to
dryness under a stream of N2.
2.3. Preparation of standard pentafluorobenzyl esters
Total long-chain fractions from standard cells were transferred
to 8.5 ml Pyrex tubes, with PTFE-lined caps. Pentafluorobenzyl
(PFB) esters were prepared by tube rotator mixing, for 1 h, with
phase-transfer catalyst solution (NaOH [0.8 g] and tetra-n-buty-
lammonium hydrogen sulfate [3.39 g] in distilled water [100 ml])
(2 ml) and pentafluorobenzyl bromide [5 g] in dichloromethane
[100 ml] (1 ml).44 The upper aqueous layer was removed and the
lower organic layer was washed successively with 10% aqueous HCl
(1 ml) and distilled water (1 ml). The organic layer was evaporated
to dryness under N2.
The dried residues were dissolved in minimal heptane. Each
solution was applied to a 500 mg/4 ml Alltech 209250 normal
phase cartridge (Alltech Associates, Carnforth, Lancashire, UK), pre-
washed with heptane, and the solvent was allowed to evaporate
completely. An International Sorbent Technology (IST) Vacmaster
FlashVac 20 vacuum tank, with a vacuum of0.35 Torr, was used to
fractionate the samples, according to the solvent elution regime
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dryness under N2 and analysed by TLC (Merck 1.05554.001 silica gel
60 F254 aluminium-backed plates) developed with petroleum ether
60–80 C:ethyl acetate, 9:1. The mycocerosic acid PFB esters were
eluted in fractions 2 and 3 (Rf¼w0.7) (Figure 2).
2.4. HPLC purification of mycocerosate PFB esters
Fractions 2 and 3 from the preliminary normal phase cartridge
separation were analysed by normal phase HPLC. The system used
was a Gilson 305 HPLC pump with an Applied Biosystems 759A UV
detector (263 nm). The column was a Jones Chromatography
(Hengoed, Cardiff, UK) Genesis silica 4 mm particle size, 250 mm by
4.6 mm i.d. The isocratic solvent system was 98:2 heptane:ethyl
acetate (1 mlmin1) and the columnwas maintained at 30 C. This
system allowed the clear separation of multimethyl-branched fatty
acid PFB esters (retention factor k0 ¼ 0.24) from other PFB fatty acid
esters (retention factors k0 ¼ 0.64–0.88). A standard sample of
mycocerosate PFB ester had a retention factor k0 of 0.22 in this
system (see Figure 3 and Table 2).
Two co-markers were developed to facilitate collection of the
correct fraction eluting from the column. To allow detection at
a similar UV wavelength, a range of compounds, with penta-
fluorophenyl chromophores and suitable polarities, were investi-
gated. It was found that decafluorobenzophenone (DFBP) (Figure 3)
(Fluorochem, Glossop, Derbyshire, UK) (retention factor k0 ¼ 0.29)
eluted just after the multimethyl-branched fatty acid PFB esters
(retention factor k0 ¼ 0.22). To obtain a co-marker which eluted just
before the mycocerosate peaks, a range of long-chain (C6, C8, C12,
C16 and C18) esters of decafluorobenzhydrol were prepared by
reaction with hexanoyl, octanoyl, dodecanoyl, hexadecanoyl and
octadecanoyl chlorides, as follows. Decafluorobenzhydrol (50 mg,
1.4104 mol) was placed in an 8.5 ml PTFE capped tube and
dissolved in anhydrous dichloromethane (2 ml). The appropriate
acid chloride (1.4104 mol) was added along with 4-dimethyla-
minopyridine (17 mg, 1.4104 mol). The solution was shaken
thoroughly and left to stand overnight at room temperature. The
solution was washed with 10% aqueous HCl (21 ml), followed by
distilled water (21 ml), and dichloromethane evaporated under
N2. The products were purified by preparative TLC in petrol
40–60 C:ethyl acetate, 9:1, Rf¼w0.8. The 1H NMR (200 Hz,
CDCl3) spectrum of dodecanoic acid bis-pentafluorophenyl-methyl
ester showed d: 0.8 (t, 3H, CH3), 1.2 (m, 16H, 8 CH2), 1.6 (m, 2H,10 15 20 25 30
C
26
C
27
C
29
C
31
C
32
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Minutes
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Figure 4. The total ion count (TIC) of PFB esters of the multimethyl-branched acids of
M. tuberculosis. The TIC (m/z 350–550) was achieved using a Varian 1200L Quad MS
(CImethane),withaZebronZB-5 (5%phenyl, 95%dimethylpolysiloxane)30 mby0.25 mm
by0.25 mmcapillarycolumnandHeas the carrier gas. The reactant gaswasmethane set at
3.6 Torr. The separationwasachievedusinga temperatureprogramof200–300 Cata rate
of 20 Cmin1, holding for 40 min. The mycolipenate peak (MC) is identified (m/z 407).COCH2CH2), 2.4 (t, 2H, COCH2), 7.2 (s, 1H, CH); the spectra of the
other esters were essentially the same, with varying intensity for
the long-chain signals.
Normal phase HPLC of the potential co-markers (Table 2) indi-
cated that dodecanoic acid bis-pentafluorophenyl-methyl ester
(DPFM) (Figure 3) was suitable as a co-marker (retention factor
k0 ¼ 0.12), eluting prior to the mycocerosic acid PFB esters.
Optimum concentrations of the markers were chosen as the
minimum amount that could be clearly seen at the maximum
sensitivity of the UV detector. For the co-marker DPFM, this was
determined to be 0.01 M in heptane; for co-marker DFPB this was
determined to be 0.005 M in heptane. The solutions were mixed in
a 1:1 ratio and 2.5 ml was added to each injection sample.2.5. Extraction and purification of natural biomarkers
The non-hydroxylated fatty acid fractions, extracted from bone
samples, were converted to PFB esters as detailed above. The crude
esterswere further fractionated using a normal phase Alltech 209250
cartridge, IST Vacmaster vacuumtankand elution system(Table1), as
outlined above. Fractions 2 and 3 from these separations were
combined, evaporated to dryness, dissolved in HPLC grade heptane
(20 ml) and 2.5 ml of the co-marker solution added, corresponding toFigure 5. The HPLC separation of multimethyl-branched PFB esters (MY) from
non-multi-methyl branched PFB esters (FA) in a M. tuberculosis cell extract (1) and
archaeological bone Coimbra sample 8 (2), containing the two co-markers dodecanoic
acid bis-pentafluorophenyl-methyl ester (DPFM) and decafluorobenzophenone (DFPB).
Column, Genesis silica 4 mm particle size, 250 mm by 4.6 mm at 30 C. Eluent, 98:2
heptane:ethyl acetate (1 mlmin1), 263 nm. FA refers to probable PFB esters of
non-hydroxylated fatty acids from endogenous bone lipids and M. tuberculosis.
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fluorophenyl-methyl ester and 6.251010 mol decafluor-
ophenylbenzophenone. The solution was evaporated to dryness
under N2. HPLC grade heptane (10 ml) was added to each sample and
the sample was injected into the HPLC system. As above, the column
was aGenesis silica 4 mmparticle size, 250 mmby4.6 mmi.d. and the
isocratic solvent systemwas98:2heptane:ethyl acetate (1 mlmin1),
withdetection at 263 nm.Collection of themycocerosate PFB fraction
beganwhenthepeakof theco-markerDPFMappearedandcontinued
until the appearance of the co-marker DFBP; the collected fraction
was evaporated to dryness under N2. Between sample injections, the
syringe was washed 40 times with HPLC grade heptane and the
Rheodyne injection valve was washed 10 times in both the load and
inject position. Blanks (heptane) were injected between each sample
to ensure there was no cross-contamination.
2.6. NI–CI GC–MS conditions for analysis of PFB esters
SIR NI–CI GC–MS analyses of the purified PFB fractions were
carried out at the Universities of Greenwich and Salford. In the
initial study (Greenwich), a 30 m by 0.25 mm i.d. by 0.25 mm film
(Scientific Glass Engineering, Milton Keynes, UK) BPX-5 (5% phenyl
polysilphenyl-siloxane) capillary column (He carrier gas, columnFigure 6. SIM chromatogram of purified mycocerosic acid PFB esterhead pressure 10 psi; CI ammonia) was used in a VG 305 MS, using
a 15 C/min temperature gradient from 175 to 300 C. The dried
samples were dissolved in 20 ml octane, and 1 ml introduced
through an autoinjector in splitless injection mode. Octane blanks
were injected between samples.
In the quantitative study (Salford), a Varian 1200L Quad MS
(CI methane, 3.6 Torr) was fitted with a Phenomenex (Macclesfield,
Cheshire, UK) Zebron ZB-5 (5% phenyl, 95% dimethylpolysiloxane)
30 m by 0.25 mm i.d. by 0.25 mmfilm capillary column, using a head
pressure of 8 psi and a gradient from 200 to 300 C at 20 C/min
and holding at this temperature for 40 min. The ion source
temperature was 260 C, the injector 250 C and the transfer line
300 C. The dried samples were dissolved in 20 ml octane, and 1 ml
injected, using direct splitless injection. Octane blanks were
analysed between samples, with a temperature range from 200 to
350 C at 20 Cmin1, over 27.5 min. Data were collected, using
Varian MS Workstation software, version 6.2.
At Greenwich, it was possible to monitor a wide range of ions,
but the data system did not allow the collection of quantitative
data; the ions studied were m/z 395 (C26 mycocerosic acid), 409
(C27), 437 (C29), 451 (C30), 479 (C32), 493 (C33) and 507 (C34).
Additionally, most extracts were monitored for m/z 407, corre-
sponding to C27 mycolipenate (Figure 1). In the light of thes from M. tuberculosis PN, using a BPX-5 column in Greenwich.
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obtaining quantitative data for the main characteristic m/z 437
(C29), 451 (C30) and 479 (C32) mycocerosate ions, measuring peak
areas. A C31 standard, hentriacontanoic acid PFB ester,m/z 465, was
used for relative retention and calibration studies at Salford.
3. Results and discussion
3.1. Extraction and purification of long-chain compounds
The PDIM waxes are extremely resistant to hydrolysis in
aqueous media.45 To obtain efficient release of the mycocerosic
acids and phthiocerol components of PDIMs, the current low water
alkaline hydrolysis procedure was developed.37,38 The suitability of
this protocol was demonstrated by the efficient release of long-
chain compounds from the standard mycobacteria. The water-
limited conditions of the alkaline hydrolysis stage were also
designed to promote racemization of the chiral centre at carbon-2
of the mycocerosates to produce diagnostic diastereoisomers dueTable 3
Correlation of mycocerosic acid detection with the burial record and state of bone prese
Lab. No. Coimbra No. State* Cause of death
1 6 G Enteric TB
2 88 P Pulmonary gangrene
3 229 M Pulmonary TB
4 355 P Pulmonary TB
5 289 G Pulmonary TB
6 59 P Meningitis
7 94 P Chronic bronchitis
8 239 M Pulmonary TB
9 210 G Typhoid fever/heart
10 252 G Pulmonary TB
11 338 M Pulmonary TB
12 36 G Pulmonary TB
13 403 G Pulmonary TB
14 286 M Peritoneal/pleural TB
15 416 P Pulmonary TB
16 114 G Spine column fractu
17 178 P Tumour on mediasti
18 226 G Bilateral pulmonary
19 104 P Bilateral bronchopne
20 412 G Meningitis TB
21 47 P Pulmonary TB
22 401 M Pulmonary TB
23 432 P Pulmonary TB
24 349 G Devastating haemop
25 473 P Pulmonary TB
26 123 P Cardiac arrhythmia
27 120 G Aorta aneurysm
28 105 M Pulmonary TB
29 70 G Pneumonic
30 16 M Enteritis/meningitis
31 181 P Pulmonary TB
32 196 P Pulmonary TB
33 171 G Pulmonary TB
34 72 M Cardiac arrhythmia/p
35 80 P Pulmonary TB
36 110 M Pneumonia
37 116 G Heart failure
38 306 G Pulmonary TB
39 113 P Epilepsy
40 246 G Pulmonary TB
41 85 G Myocarditis/meninge
42 35 M Chronic endocarditis
43 56 M Heart lesion
44 62 M Brain haemorrhage
45 17 P Brain haemorrhage
46 98 M Heart failure/myocar
47 108 P General paralysis
48 68 G Alcoholism and sudd
49 24 M Dorsal ‘‘astomo’’
* State of preservation of the bone, as judged by weight and friability alone. (G¼ goodto the presence of an additional chiral methyl branch at carbon-4.
As shown later, these diastereoisomers can be distinguished on gas
chromatography of their PFB esters, visible as a second smaller peak
immediately following the major peak. In contrast, mycolipenic
acid derivatives produce a single peak as there is no chiral centre at
carbon-2 (Figure 4).
The released acidic components of hydrolysates were converted
to PFB esters by an efficient phase-transfer catalysis procedure.44
Long-chain components were separated on silica gel cartridges to
produce fractions enriched in multimethyl-branched PFB esters,
PFB esters of mycolates and underivatised phthiocerols, as shown
in Figure 2 for standard extracts ofM. tuberculosis. Fractions 2 and 3,
contained themultimethyl-branched PFB esters (Figure 2), but they
were accompanied by the usual C12–C18 fatty acids, found in cellular
plasma membrane lipids. To ensure effective GC–MS analyses,
these fractions were further purified by normal phase HPLC.
The HPLC profile for the combined fractions 2 and 3 from
standard M. tuberculosis is shown in Figure 5. As shown by
comparison with standard PFB mycocerosates, the multimethyl-rvation.
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Table 4
Distribution of mycocerosates and mycolipenates in Coimbra bone extracts and
standard material. Semi-quantitative data were obtained in Greenwich (G) and
quantitative ratios of C29, C30 and C32 mycocerosate ionswere recorded in Salford (S).
Sample C27 C27 C29 C29 C30 C30 C32 C32
m/z 407 409 437 437 451 451 479 479
Laboratory G G G S G S G S
M. marinum 0.71 0.28 0.01
M. kansasii 0.16 0.80 0.04
M. bovis 0.77 0.13 0.10
M. tuberculosis 0.34 0.25 0.41
1 þ þþþ 0.27 þ 0.13 þþþ 0.60
2 þþþ 0.25 þþ 0.26 þþþ 0.49
3 þþþ 0.29 þþ 0.18 þþþ 0.53
4 þ þþþ 0.25 þþ 0.22 þþþ 0.52
5 ND þþþ 0.16 þþ 0.13 þþþ 0.71
6 þþþ þþþ 0.12 þþ 0.16 þþþ 0.72
8 þ þþ þþþ 0.21 þþ 0.19 þþþ 0.60
9 þ þþþ þþþ 0.15 þþ 0.17 þþþ 0.68
10 þ þþ þþþ 0.13 þþ 0.14 þþþ 0.73
11 þ þþþ 0.12 þþ 0.17 þþþ 0.71
12 þþþ 0.27 0.18 þþþ 0.55
13 þ þþþ 0.32 þþ 0.19 þþþ 0.49
14 þþþ 0.14 þþ 0.13 þþþ 0.73
15 þþþ 0.25 0.12 þþþ 0.63
16 þþþ 0.42 0.20 þþþ 0.38
17 þþþ 0.21 þþþ 0.17 þþ 0.62
18 þþþ 0.22 þþþ 0.15 þþþ 0.63
19 þ þþþ 0.17 þþ 0.12 þþþ 0.71
20 þþþ 0.24 þþþ 0.13 þþþ 0.63
21 þþþ 0.26 þþ 0.18 þþþ 0.56
22 þþþ 0.18 þþþ 0.36 þþþ 0.46
23 þþþ 0.33 þþþ 0.14 þþþ 0.53
24 þþþ 0.35 0.19 þþþ 0.46
25 þþþ 0.23 þþ 0.11 þþþ 0.66
26 þþþ 0.63 þþ 0.10 þþþ 0.27
27 0.37 0.11 0.52
28 þþ þþþ 0.40 þþ 0.28 þþþ 0.32
29 þ þþþ 0.43 þþ 0.13 þþþ 0.44
30 þþþ 0.44 þþ 0.18 þþþ 0.38
31 þþþ 0.43 þþ 0.11 þþþ 0.46
33 0.58 0.26 0.16
35 þþþ 0.19 þþ 0.18 þþþ 0.63
38 þþ 0.07 þþ 0.04 þþþ 0.89
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smaller PFB esters. Any PFB mycocerosate esters present in an
archaeological sample would be below the UV detection limit, so
suitable co-markers, DPFM and DFBP, were developed (Figure 5),
eluting immediately before and after the mycocerosates. This
allowed successful collection and purification of the mycocerosate
fractions from archaeological material.
The co-markers were chosen to have essentially the same UV
chromophore as the PFB esters. Conveniently, decafluor-
obenzophenone(DFBP) (Figure3)was foundtoelute justafter thePFB
fraction containing the PFB mycocerosates. To obtain a suitable
marker, eluting before the PFB mycocerosates, a range of long-chain
esters of decafluorobenzhydrolwere prepared (Table 2); itwas found
that dodecanoic acid bis-pentafluorophenyl-methyl (DPFM) ester
eluted just before the PFB fraction containing the PFB mycocerosates
(Figure 5). Standard solutions were prepared for addition to the
archaeological samples.
3.2. Diagnostic ion selection
Using the mycocerosic acid fraction from the standard
M. tuberculosis,M. marinum,M. bovis andM. kansasii cells (data not
shown), which correlated with published data,38 ions at m/z 395
(C26 mycocerosic acid), 409 (C27), 437 (C29), 451 (C30), 479 (C32),
493 (C33) and 507 (C34) were scrutinised in the initial study of the
archaeological samples at Greenwich. Additionally, in the majority
of the analyses the C27 mycolipenate ion atm/z 407 was monitored.
No definitive ion signals were observed for the dimethyl-branched
C26, pentamethyl-branched C33 and tetramethyl-branched C34
mycocerosates and these acids were excluded from this study. The
C27 mycocerosate ion (m/z 409) has value as a marker for
M. marinum and M. bovis, being prevalent in both species31,38,40;
M. kansasii did not appear to be a contaminant of the site, as the
profiles had major amounts of the C32 mycocerosate. The most
intense ions present in mycocerosic acid fraction from the standard
M. tuberculosis PN cells (Figure 6) werem/z 437 (C29),m/z 451 (C30)
and m/z 479 (C32), in agreement with previous studies
31,36,38,40;
these ions were used for quantitative screening at Salford.
3.3. The sample set
The chosen individuals had been clinically examined between
1837 and 1936. Current TB diagnosis uses abnormal chest radio-
graph findings consistent with TB, fever, weight loss, a history of TB,
a positive result on tuberculin skin test and haemoptysis. The initial
indications are supported by laboratory confirmation, but even
with all these modern tools, a diagnosis of TB is sometimes
missed.46 The sample set did not include individuals less than 15
years old at death, since diagnosis without laboratory support is
much more problematic in children.47 In modern cases, primary
disease and its complications are more common in children than in
adults, leading to differences in both clinical and radiographic
manifestations48; the sample set, therefore, was restricted to
adults. The sample set was designed to include 50% of individuals
recorded to have died from tuberculosis (Table 3).
3.4. Initial study (Greenwich)
Summaries of the results obtained at the two centres are shown
in Tables 3 and 4. In the initial analyses, carried out at Greenwich, it
was possible to monitor seven negative ions (m/z 395, 409, 437, 451,
479, 493, 507), corresponding to C26, C27, C29, C30, C32, C33 and C34
mycocerosate carboxylates, as well asm/z 407, corresponding to the
C27 mycolipenate (Table 4). A typical profile for a strongly positive
bone sample (C8), determined in Greenwich, is shown in Figure 7.As expected, C29, C30 and C32mycocerosates were present, but there
was also a comparable C27 mycocerosate. No evidence was seen for
C26, C33 or C34 mycocerosates in C8 or in any of the other bone
extracts studied. The peak at 9:38 for m/z 395 (Figure 7) is not C26
mycocerosate; it is not a double peak and its retention time does
not coincide with that (10:32) of C27 mycocerosate, as shown in the
profile (Figure 6) for the standard mycocerosates from M. tubercu-
losis. The profile for C8, did, however, show the presence of a signal
attributable to C27 mycolipenate and several other extracts were
positive. The presence or absence of mycolipenates in the Coimbra
bone extracts is summarized in Table 4. The low intensity of them/z
407 signal, in a minority of samples (Table 4), indicated that the
mycolipenate ion is a less effective biomarker for tuberculosis.3.5. Quantitative study (Salford)
Using standard M. tuberculosis PN cells and hentriacontanoic
acid (C31, m/z 465) as an internal marker, the relative retention of
the C29, C30 and C32 ions on the Zebron ZB-5 columnwas 0.46, 0.47
and 0.63, respectively. To ascertain system performance, a six point
calibration of hentriacontanoic acid, 18–3500 nM l1 was under-
taken. The linearity of the system was good, with a regression
coefficient of 0.9995. The detection limit was calculated as
1.34 femtomoles, defined as twice the average peak to peak
Figure 7. SIM chromatogram of purified multimethyl-branched PFB esters from Coimbra sample 8, using a BPX-5 column in Greenwich. The component with a retention time of
10.45 min, corresponds to C27 mycolipenate (m/z 407).
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structure, a similar response was assumed for each component.
A GC–MS total ion count (TIC) profile of the multimethyl-branched
fraction purified from M. tuberculosis PN is shown in Figure 4. As
well as the expected mycocerosates, a substantial amount of C27
mycolipenate is present as a single peak.
At Salford, the analysis was limited to the trimethyl-branched
C29 (m/z 437) and tetramethyl-branched C30 (m/z 451) and C32 (m/z
479) mycocerosates in order to obtain good quantitative data. The
C32 mycocerosate (Table 4) is usually the major component in M.
tuberculosis resulting in the ion m/z 479, as shown in previous
studies,36–40 with the double peaks for C29 (m/z 437) and C30 (m/z451) also present (Table 4). Typical profiles for the same strong
positive sample (C8), as recorded at Greenwich (Figure 7), and
a weak positive (C26) are shown in Figure 8.
3.6. Correlation of results
The results summarized in Table 4 provide a good correlation
between the two separate Greenwich and Salford analyses.
However, the enhanced sensitivity of the more focused study, in
Salford, was able to detect two additional positive extracts (Table 4,
C27, 33). The data for the positive samples from theCoimbra extracts
are correlated in Table 3. It is notable that in the less quantitative
Figure 8. SIM chromatograms for Coimbra sample 8, a strong positive (1) and sample 26, a weak positive (2), using a Zebron ZB-5 column in Salford.
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wereapparentlyenhanced (Table3).Of the49 ribs analysed,16 (33%)
were negative and others displayed various degrees of positivity. In
most of the 33 positive cases (Table 3) the principle components
were the C29 and C32 mycocerosates, at m/z 437 and 479. This is in
accordwith theprofiles ofmycocerosates inM. tuberculosis.36–40 The
C32 mycocerosate was the major component in 28 (85%) of the 33
positive samples and in 7 of these (Table 4; C5, 6, 10, 11, 14, 19, 38) it
comprisedmore than70%of themycocerosates (Table 4).Of these28
samples, 23 had C29 as the next most abundantmycocerosate (Table
4; C1, 2, 3–5, 8,12–15,17–21, 23–25, 27, 29, 31, 35, 38) andC29was the
major mycocerosate in 5 (Table 4; C16, 26, 28, 30, 33) of the 33
positive samples. The C30 mycocerosate was usually the minor
component, except for 6 samples (Table 4; C2, 6, 9–11, 22) where it
predominated over the C29 ester.
It is of interest to correlate the mycocerosic acid detection to the
burial record (Table 3). Of the 33mycocerosate positive samples, 22
of these correlated with a positive diagnosis for tuberculosis; only 2
skeletons diagnosed with pulmonary tuberculosis were negative
for mycocerosates (Table 3; C32, 40). Eleven isolates (Table 3; C2, 6,
9, 16, 17, 19, 24, 26, 27, 29, 30) were positive for mycocerosates
without an indication of tuberculosis; this indicates that specific
lipid biomarkers can detect tuberculosis before bone lesions, or
other physical manifestations, appear.
3.7. Preservation potential of the biomarker
The diagnosis of tuberculosis in archaeological skeletal samples
can be more difficult than for living patients, as there is no living
patient to assess signs and symptoms and often no associated
specific pathological change. Another problem, aside from site
contamination, is the diagenetic (post-mortem modification by
a variety of routes) alteration of the biomarker. Although more
resistant than other types of biomolecule,49 lipids such as myco-
cerosic acids are potentially susceptible to diagenetic change. The
main route of diagenesis for many lipids is hydrolysis of the ester
bond followed by decarboxylation50; generally, long-chain fatty
acids (C20–C34) are more resistant than shorter chain analogues.
51Diagenetic change, resulting in mycocerosic acid decarboxylation
would make the resulting alkane undetectable, as it could not be
derivatised.
There is also a hierarchy for stability with unsaturated fatty acids
being more reactive than branched fatty acids, which are more
reactive than straight-chain fatty acids.52 It is unlikely, however,
that diagenetic reactions would result in an enrichment with
longer chain mycocerosic acids, since no simple relationship exists
between the rate of diagenetic loss and chain length.53,54 High
concentrations of C32 mycocerosate surviving in the bone are
therefore strongly indicative of members of the M. tuberculosis
complex, allowing no confusion with any other mycobacteria.
The form in which these lipids exist in the bone may have an
effect on survival. Mycocerosic acids are diesterified to the
phthiocerols, with the resultant phthiocerol dimycocerosate being
over 100 carbons in size and highly resistant to hydrolysis.45
Additionally, mycocerosic acids are present as the lipid moiety in
phenolic glycolipids (PGLs) found inM. bovis and unusual ‘‘Canetti’’
variants of M. tuberculosis.32,33,35 The hydrophilic sugar moieties of
PGLs might be relatively more susceptible to diagenetic loss.
The detection of C27 mycolipenates in a significant number of
samples (Table 4) is interesting. Mycolipenates occur as diacyl
trehaloses33 and these relatively polar glycolipids would be
expected to degrade more rapidly. However, diacyl trehaloses are
less regularly encountered than phthiocerol dimycocerosates,33 so
it is unclear if the reduced detection (Table 4) is due to selective
diagenesis, perhaps due to the presence of a double bond, or limited
synthesis in the original infecting agent.
Preservation of fatty acids would be further enhanced from their
inclusion into microbially inaccessible matrices.55 Fatty acids
adsorb to the surface pores of natural geosorbents56 and are pro-
tected from degradation.55 Fatty acids not protected by mineral
pores have an average turnover time of between 21 and 49 years.57
Bone contains such small pores54,58 and it is hypothesized that
these afford protection for the mycobacterial lipids. Bones were
graded as good, moderate and poor (Table 3), but the degree of
bone degradation did not appear to have an effect on mycocerosate
recovery.
J.E. Redman et al. / Tuberculosis 89 (2009) 267–2772764. Conclusions
Mycocerosic acid biomarkers, for M. tuberculosis, have been
identified in archaeological samples for the first time, using the
Coimbra Identified Skeletal Collection41,42 as a test case. The
analytical procedure is designed to be a component of an integrated
method designed to maximise the amount of information from
a range of characteristic lipid biomarkers. When considering
destructive analysis of irreplaceable material, such as archaeolog-
ical samples, it is of paramount importance to preserve all extracted
material in a stable form. Such extracts would then be available for
future analysis, using increasingly sophisticated and sensitive
procedures.
In the present procedure, efficient alkaline hydrolysis is fol-
lowed by conversion of acidic components to stable PFB esters.
Reproducible normal phase cartridge protocols then separate
potential long-chain biomarkers into three main fractions for
separate analysis. The first eluting non-hydroxylated PFB esters can
be analysed by negative ion chemical ionisation gas chromatog-
raphy mass spectrometry to record characteristic profiles of
mycocerosic acids and any other potential biomarker acids, such as
the mycolipenic acids detected in some of the present samples. The
next fraction contains the hydroxylated mycolic acid PFB esters and
a new procedure has been devised to analyse these by fluorescence
HPLC of 1-pyrenebutyric acid ester derivatives.59 The final fraction
from the cartridge separation contains the phthiocerol family
which could be derivatised with PBA for fluorescence HPLC or
a variety of other sensitive procedures.
Analysis of mycocerosic acid biomarkers, introduced in this
study, adds another weapon in the search for information regarding
ancient mycobacterial disease in archaeological materials. Lipid
biomarkers, such as mycocerosic and mycolic acids, are particularly
robust and are ideal in complementing detection of ancient
DNA.11,29,59 In certain cases, mycolic acid biomarkers have been
detected in archaeological samples which have been found nega-
tive for M. tuberculosis DNA.11Acknowledgements
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